Reach your audience. Get results.
Rely on the experience, guidance, and superior media targeting of Business Wire for your global press release distribution.
Public RelationsMaximize the reach of your news with our press release distribution services and partnerships. Investor RelationsReach and engage investors, shareholders, analysts, and media with our complete suite of IR services and tools. Distribution & AnalyticsTarget your news, reach your audiences, and understand the impact of your press releases with our analytics reports. |
Latest News
Today is May 19, 2024.
All times in Eastern Daylight Time.
-
Kyocera Corporation to Exhibit at Automotive Engineering Exposition 2024KYOTO, Japan--(BUSINESS WIRE)--Kyocera Corporation (President: Hideo Tanimoto) announced its participation in the Automotive Engineering Exposition 2024 in Pacifico Yokohama, Kanagawa Prefecture Ma... more »
-
株式会社ピューズ・人とくるまのテクノロジー展2024 横浜 出展のお知らせ横浜--(BUSINESS WIRE)--(ビジネスワイヤ) -- 電気自動車の車両開発、テクニカルコンサルティング、部品販売を行う(株)ピューズ(本社:神奈川、代表取締役社長:松本浩征、www.pues.co.jp)は、「人とくるまのテクノロジー展2024 横浜 ~公益社団法人 自動車技術会~」に出展いたしますので、お知らせいたします。 本展示会では、研究開発・試作、製品開発、少量生産、部... more »
-
香港--(BUSINESS WIRE)--(ビジネスワイヤ) -- オアシス・マネジメント・カンパニー・リミテッド(以下「オアシス」)は、製紙会社である、北越コーポレーション株式会社(以下「北越」または「同社」)(証券コード:3865)の株式を約 18%を保有するファンド運用会社です。オアシスは「責任ある機関投資家」の諸原則《日本版スチュワードシップ・コード》を遵守しており、この原則に沿って... more »
-
HONG KONG--(BUSINESS WIRE)--Oasis Management Company Ltd. (“Oasis”) is the manager to funds that beneficially own approximately 18% of Japanese paper manufacturer Hokuetsu Corporation (3865 JT) (“H... more »
-
New data presented at ATS 2024 show the potential of TEZSPIRE to play a role in the future treatment of chronic obstructive pulmonary diseaseWILMINGTON, Del.--(BUSINESS WIRE)--The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of ... more »
-
New Phase 2a Clinical Trial Results Demonstrate Endeavor BioMedicines’ ENV-101 Improved Lung Function and Reversed Key Measures of Lung Fibrosis in Patients With Idiopathic Pulmonary FibrosisSAN DIEGO--(BUSINESS WIRE)--Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life... more »
-
Zhengzhou : des expositions interactives à l’occasion de la Journée internationale des muséesZHENGZHOU, Chine--(BUSINESS WIRE)--Dans la ville de Zhengzhou, dans le centre de la Chine, la visite des musées est devenue une nouvelle tendance du mode de vie urbain. Le 18 mai, à l’occasion de l... more »
-
Savara Presented New Data on Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the American Thoracic Society (ATS) International Conference 2024LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thorac... more »
-
SharkNinja Announces David Beckham as Global Brand Ambassador for Ninja BrandNEEDHAM, Mass.--(BUSINESS WIRE)--SharkNinja, Inc. (NYSE: SN), a global product design and technology company, is pleased to announce that David Beckham has joined forces with the Ninja brand as a g... more »
-
Zhengzhou: Interactive Exhibitions on the International Museum DayZHENGZHOU, China--(BUSINESS WIRE)--Zhengzhou, one of China’s eight ancient capitals, boasts a total of 112 museums. more »
-
Reality TV Star, Mollie Pearce, Backs Campaign to Tackle Inequalities in Condition That Impacts Millions of People GloballyINCHEON, South Korea--(BUSINESS WIRE)--Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where’s Crohn’s & Colitis (CC)? campaign for this year’s World IBD ... more »
-
LITTLE ROCK, Ark.--(BUSINESS WIRE)--Dillard’s, Inc. (NYSE: DDS) (the “Company” or “Dillard’s”) announced that the Board of Directors declared a cash dividend of $0.25 per share on the Class A and C... more »
-
xFusion desvela el futuro de la HPC en ISC 2024HAMBURGO, Alemania--(BUSINESS WIRE)--xFusion Digital Technologies Co., Ltd. (xFusion) impresionó a los asistentes con sus productos y soluciones informáticos de gama alta en el prestigioso evento I... more »
-
Vorstellung des HPC Future mit xFusion auf der ISC 2024HAMBURG, Deutschland--(BUSINESS WIRE)--xFusion Digital Technologies Co., Ltd. (xFusion) hat Teilnehmer mit seinen hochwertigen Produkten und Lösungen auf der prestigeträchtigen ISC High Performance... more »
-
TDOC INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Teladoc Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitSAN DIEGO--(BUSINESS WIRE)--The suit alleges defendants issued false statements concerning Teladoc business and prospects, resulting in its stock trading at inflated prices. more »